IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Outlook Therapeutics Inc (ONSGBP)

Q2 2024 vs Q3 2024

Comparing institutional holders between quarters

Quarters

Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023
CompareDetailedHistoricalFundsOptions13D/13GPeersTargetingTrading SummaryProfile
Rosalind Advisors, Inc.
UNCHANGED
Shares450,000 from 450,000
Change0 (0%)
Value$2.4M (-$918.0K)
Filed 2024-10-30
Status
Rosalind Advisors, Inc.
UNCHANGED450,000450,00000%$3.3M$2.4M-$918.0K2024-10-30
Showing 1 of 1 institutions